BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200506T140000
DTEND;TZID=America/Vancouver:20200506T150000
DTSTAMP:20260417T070423
CREATED:20200504T181048Z
LAST-MODIFIED:20200504T181048Z
UID:8951-1588773600-1588777200@scienceinboston.com
SUMMARY:Virtual Microbiome Seminar Series
DESCRIPTION:
URL:https://scienceinboston.com/event/virtual-microbiome-seminar-series/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/Microbiome-seminar-series-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200506T140000
DTEND;TZID=America/Vancouver:20200506T150000
DTSTAMP:20260417T070423
CREATED:20200504T181048Z
LAST-MODIFIED:20200504T181048Z
UID:27479-1588773600-1588777200@scienceinboston.com
SUMMARY:Virtual Microbiome Seminar Series
DESCRIPTION:
URL:https://scienceinboston.com/event/virtual-microbiome-seminar-series-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/Microbiome-seminar-series-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200506T130000
DTEND;TZID=America/Vancouver:20200506T140000
DTSTAMP:20260417T070423
CREATED:20200415T182215Z
LAST-MODIFIED:20200415T182215Z
UID:8695-1588770000-1588773600@scienceinboston.com
SUMMARY:STAT Digital Event: Vaccines. Can They Come Soon Enough?
DESCRIPTION:Join STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19.\n\n\n\n\n\n\nAbout this Event\n\n\nThe pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nSchedule: Please note\, dates and times are subject to change as the story evolves. \nPart 3: Vaccines. Can they come soon enough? May 6\, 2020 at 1PM EST \n\nTal Zaks\, chief medical officer\, Moderna\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinboston.com/event/stat-digital-event-vaccines-can-they-come-soon-enough/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/STAT-Digital-Event-Series-Combating-Covid-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200506T130000
DTEND;TZID=America/Vancouver:20200506T140000
DTSTAMP:20260417T070423
CREATED:20200415T182215Z
LAST-MODIFIED:20200415T182215Z
UID:27451-1588770000-1588773600@scienceinboston.com
SUMMARY:STAT Digital Event: Vaccines. Can They Come Soon Enough?
DESCRIPTION:Join STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19.\n\n\n\n\n\n\nAbout this Event\n\n\nThe pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nSchedule: Please note\, dates and times are subject to change as the story evolves. \nPart 3: Vaccines. Can they come soon enough? May 6\, 2020 at 1PM EST \n\nTal Zaks\, chief medical officer\, Moderna\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinboston.com/event/stat-digital-event-vaccines-can-they-come-soon-enough-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/STAT-Digital-Event-Series-Combating-Covid-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200506T110000
DTEND;TZID=America/Vancouver:20200506T130000
DTSTAMP:20260417T070423
CREATED:20200417T173003Z
LAST-MODIFIED:20200417T173003Z
UID:8745-1588762800-1588770000@scienceinboston.com
SUMMARY:2020 Virtual Grant Writing Series
DESCRIPTION:Are you working on a grant proposal and want to make your application stand out? \nJoin us for the 2020 Virtual Grant Writing Series\, offered by Professional Development and Postdoctoral Affairs. This 6-week series focuses on how to clearly and concisely express the significance\, approach\, and innovation of your study. After learning about effective writing strategies and grant mechanics\, you’ll have dedicated writing time and receive peer feedback on your proposal. \nAll disciplines are welcome to attend. You are encouraged to attend all 6 sessions! \nLocation: Zoom \nDates: \n\nWednesday\, April 29th 11AM – 1PM\nWednesday\, May 6th 11AM – 1PM\nWednesday\, May 13th 11AM – 1PM\nWednesday\, May 20th 11AM – 1PM\nWednesday\, May 27th 1PM – 3PM (note time difference)\nWednesday\, June 3rd 11AM – 1PM
URL:https://scienceinboston.com/event/2020-virtual-grant-writing-series-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200506T110000
DTEND;TZID=America/Vancouver:20200506T130000
DTSTAMP:20260417T070423
CREATED:20200417T173003Z
LAST-MODIFIED:20200417T173003Z
UID:27461-1588762800-1588770000@scienceinboston.com
SUMMARY:2020 Virtual Grant Writing Series
DESCRIPTION:Are you working on a grant proposal and want to make your application stand out? \nJoin us for the 2020 Virtual Grant Writing Series\, offered by Professional Development and Postdoctoral Affairs. This 6-week series focuses on how to clearly and concisely express the significance\, approach\, and innovation of your study. After learning about effective writing strategies and grant mechanics\, you’ll have dedicated writing time and receive peer feedback on your proposal. \nAll disciplines are welcome to attend. You are encouraged to attend all 6 sessions! \nLocation: Zoom \nDates: \n\nWednesday\, April 29th 11AM – 1PM\nWednesday\, May 6th 11AM – 1PM\nWednesday\, May 13th 11AM – 1PM\nWednesday\, May 20th 11AM – 1PM\nWednesday\, May 27th 1PM – 3PM (note time difference)\nWednesday\, June 3rd 11AM – 1PM
URL:https://scienceinboston.com/event/2020-virtual-grant-writing-series-2-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200501T140000
DTEND;TZID=America/Vancouver:20200501T150000
DTSTAMP:20260417T070423
CREATED:20200421T193424Z
LAST-MODIFIED:20200421T193424Z
UID:8801-1588341600-1588345200@scienceinboston.com
SUMMARY:Pre-/Post-Publication Peer Review
DESCRIPTION:Pre-/post-publication peer review: You do a study\, you write up the paper\, and then you publish it. That’s it\, right? Not so fast: peer review has always been a recurring step in the scientific process\, but methods to do so are even more widespread than ever. We will talk about benefits and challenges of using preprint sites like bioRxiv\, and the wide world of peer-reviewed feedback after publishing your manuscript.
URL:https://scienceinboston.com/event/pre-post-publication-peer-review/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200501T140000
DTEND;TZID=America/Vancouver:20200501T150000
DTSTAMP:20260417T070423
CREATED:20200421T193424Z
LAST-MODIFIED:20200421T193424Z
UID:27471-1588341600-1588345200@scienceinboston.com
SUMMARY:Pre-/Post-Publication Peer Review
DESCRIPTION:Pre-/post-publication peer review: You do a study\, you write up the paper\, and then you publish it. That’s it\, right? Not so fast: peer review has always been a recurring step in the scientific process\, but methods to do so are even more widespread than ever. We will talk about benefits and challenges of using preprint sites like bioRxiv\, and the wide world of peer-reviewed feedback after publishing your manuscript.
URL:https://scienceinboston.com/event/pre-post-publication-peer-review-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200501T100000
DTEND;TZID=America/New_York:20200501T110000
DTSTAMP:20260417T070423
CREATED:20200415T223624Z
LAST-MODIFIED:20200415T223624Z
UID:8732-1588327200-1588330800@scienceinboston.com
SUMMARY:MassBio Chat On Emerging Technologies To Diagnose and Fight COVID-19
DESCRIPTION:Join us for this MassBio virtual forum via Zoom as Jacob Plieth\, Senior Reporter\, Evaluate Vantage\, moderates an expert\, scientifically focused panel on emerging technologies to fight COVID-19. The discussion will cover diagnostics\, therapeutics\, and vaccines as well as perspectives on patient-driven therapeutic approaches and global risk management. Bring your questions. Sponsored by the MassBio Drug Discovery forum working group. \nNOTE: As MassBio transitions to virtual events\, we are striving to make them as inclusive as possible given the challenges and restrictions inherent in virtual events. Thank you for your understanding.
URL:https://scienceinboston.com/event/massbio-chat-on-emerging-technologies-to-diagnose-and-fight-covid-19/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200501T100000
DTEND;TZID=America/New_York:20200501T110000
DTSTAMP:20260417T070423
CREATED:20200415T223624Z
LAST-MODIFIED:20200415T223624Z
UID:27456-1588327200-1588330800@scienceinboston.com
SUMMARY:MassBio Chat On Emerging Technologies To Diagnose and Fight COVID-19
DESCRIPTION:Join us for this MassBio virtual forum via Zoom as Jacob Plieth\, Senior Reporter\, Evaluate Vantage\, moderates an expert\, scientifically focused panel on emerging technologies to fight COVID-19. The discussion will cover diagnostics\, therapeutics\, and vaccines as well as perspectives on patient-driven therapeutic approaches and global risk management. Bring your questions. Sponsored by the MassBio Drug Discovery forum working group. \nNOTE: As MassBio transitions to virtual events\, we are striving to make them as inclusive as possible given the challenges and restrictions inherent in virtual events. Thank you for your understanding.
URL:https://scienceinboston.com/event/massbio-chat-on-emerging-technologies-to-diagnose-and-fight-covid-19-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200430T160000
DTEND;TZID=America/New_York:20200430T180000
DTSTAMP:20260417T070423
CREATED:20200406T145515Z
LAST-MODIFIED:20200406T145515Z
UID:8606-1588262400-1588269600@scienceinboston.com
SUMMARY:MIT Alumni Research Slam: Course 7
DESCRIPTION:Register to view and participate in this special edition of the MIT Alumni Research Slam\, an online-only event co-hosted by the MIT Alumni Association and the MIT Department of Biology (course 7) on Thursday\, April 30\, from 4pm-6pm ET. Alumni of course 7 in research roles from MIT and around the world will compete for $2\,000 in cash and prizes for best communicating their research to a panel of accomplished journalists and editors in a fast-paced virtual pitch competition. \nInterested in competing? Email the organizers a short summary of your current research by April 15. Eligible competitors must be MIT alums of course 7 who are either current graduate students\, postdocs or non-tenured faculty members at an accredited college or university around the world.
URL:https://scienceinboston.com/event/mit-alumni-research-slam-course-7/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200430T160000
DTEND;TZID=America/New_York:20200430T180000
DTSTAMP:20260417T070423
CREATED:20200406T145515Z
LAST-MODIFIED:20200406T145515Z
UID:27447-1588262400-1588269600@scienceinboston.com
SUMMARY:MIT Alumni Research Slam: Course 7
DESCRIPTION:Register to view and participate in this special edition of the MIT Alumni Research Slam\, an online-only event co-hosted by the MIT Alumni Association and the MIT Department of Biology (course 7) on Thursday\, April 30\, from 4pm-6pm ET. Alumni of course 7 in research roles from MIT and around the world will compete for $2\,000 in cash and prizes for best communicating their research to a panel of accomplished journalists and editors in a fast-paced virtual pitch competition. \nInterested in competing? Email the organizers a short summary of your current research by April 15. Eligible competitors must be MIT alums of course 7 who are either current graduate students\, postdocs or non-tenured faculty members at an accredited college or university around the world.
URL:https://scienceinboston.com/event/mit-alumni-research-slam-course-7-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200429T110000
DTEND;TZID=America/New_York:20200429T130000
DTSTAMP:20260417T070423
CREATED:20200417T172652Z
LAST-MODIFIED:20200417T172652Z
UID:8741-1588158000-1588165200@scienceinboston.com
SUMMARY:2020 Virtual Grant Writing Series
DESCRIPTION:Are you working on a grant proposal and want to make your application stand out? \nJoin us for the 2020 Virtual Grant Writing Series\, offered by Professional Development and Postdoctoral Affairs. This 6-week series focuses on how to clearly and concisely express the significance\, approach\, and innovation of your study. After learning about effective writing strategies and grant mechanics\, you’ll have dedicated writing time and receive peer feedback on your proposal. \nAll disciplines are welcome to attend. You are encouraged to attend all 6 sessions! \nLocation: Zoom \nDates: \n\nWednesday\, April 29th 11AM – 1PM\nWednesday\, May 6th 11AM – 1PM\nWednesday\, May 13th 11AM – 1PM\nWednesday\, May 20th 11AM – 1PM\nWednesday\, May 27th 1PM – 3PM (note time difference)\nWednesday\, June 3rd 11AM – 1PM
URL:https://scienceinboston.com/event/2020-virtual-grant-writing-series/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200429T110000
DTEND;TZID=America/New_York:20200429T130000
DTSTAMP:20260417T070423
CREATED:20200417T172652Z
LAST-MODIFIED:20200417T172652Z
UID:27460-1588158000-1588165200@scienceinboston.com
SUMMARY:2020 Virtual Grant Writing Series
DESCRIPTION:Are you working on a grant proposal and want to make your application stand out? \nJoin us for the 2020 Virtual Grant Writing Series\, offered by Professional Development and Postdoctoral Affairs. This 6-week series focuses on how to clearly and concisely express the significance\, approach\, and innovation of your study. After learning about effective writing strategies and grant mechanics\, you’ll have dedicated writing time and receive peer feedback on your proposal. \nAll disciplines are welcome to attend. You are encouraged to attend all 6 sessions! \nLocation: Zoom \nDates: \n\nWednesday\, April 29th 11AM – 1PM\nWednesday\, May 6th 11AM – 1PM\nWednesday\, May 13th 11AM – 1PM\nWednesday\, May 20th 11AM – 1PM\nWednesday\, May 27th 1PM – 3PM (note time difference)\nWednesday\, June 3rd 11AM – 1PM
URL:https://scienceinboston.com/event/2020-virtual-grant-writing-series-7/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200428T170000
DTEND;TZID=America/Vancouver:20200428T180000
DTSTAMP:20260417T070423
CREATED:20200417T205804Z
LAST-MODIFIED:20200417T205804Z
UID:8766-1588093200-1588096800@scienceinboston.com
SUMMARY:Broad@15 Talk Series: The Human Cell Atlas: ‘Google Maps’ to Navigate the Human Body
DESCRIPTION:Broad@15 Talk Series\nThe Human Cell Atlas: “Google Maps” to navigate the human body in health and disease\nAviv Regev\nChair of the Faculty and Core Member\, Broad Institute\nDirector\, Klarman Cell Observatory\, Broad Institute\nProfessor\, Department of Biology\, MIT\nInvestigator\, Howard Hughes Medical Institute \nThe average adult human has 37 trillion cells\, but despite centuries of study\, we don’t know how many different cell types there are\, their properties in health and disease\, and how they work together. Computational and systems biologist Aviv Regev will discuss how the recent breakthroughs in single cell genomics that allow us to characterize millions of cells at a time by the active genes in each individual cell has fueled efforts to build a Google Map of every cell in the body. She will also show how these maps are being used to shed light on rare disease\, cancer\, and COVID-19.
URL:https://scienceinboston.com/event/broad15-talk-series-the-human-cell-atlas-google-maps-to-navigate-the-human-body/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/Broad@15-Aviv-Regev.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200428T170000
DTEND;TZID=America/Vancouver:20200428T180000
DTSTAMP:20260417T070423
CREATED:20200417T205804Z
LAST-MODIFIED:20200417T205804Z
UID:27466-1588093200-1588096800@scienceinboston.com
SUMMARY:Broad@15 Talk Series: The Human Cell Atlas: ‘Google Maps’ to Navigate the Human Body
DESCRIPTION:Broad@15 Talk Series\nThe Human Cell Atlas: “Google Maps” to navigate the human body in health and disease\nAviv Regev\nChair of the Faculty and Core Member\, Broad Institute\nDirector\, Klarman Cell Observatory\, Broad Institute\nProfessor\, Department of Biology\, MIT\nInvestigator\, Howard Hughes Medical Institute \nThe average adult human has 37 trillion cells\, but despite centuries of study\, we don’t know how many different cell types there are\, their properties in health and disease\, and how they work together. Computational and systems biologist Aviv Regev will discuss how the recent breakthroughs in single cell genomics that allow us to characterize millions of cells at a time by the active genes in each individual cell has fueled efforts to build a Google Map of every cell in the body. She will also show how these maps are being used to shed light on rare disease\, cancer\, and COVID-19.
URL:https://scienceinboston.com/event/broad15-talk-series-the-human-cell-atlas-google-maps-to-navigate-the-human-body-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/Broad@15-Aviv-Regev.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200427T110000
DTEND;TZID=America/Vancouver:20200427T120000
DTSTAMP:20260417T070423
CREATED:20200422T173954Z
LAST-MODIFIED:20200422T173954Z
UID:8815-1587985200-1587988800@scienceinboston.com
SUMMARY:Stat Video Chat: A Conversation on the Coronavirus with Rich Besser
DESCRIPTION:Rich Besser is a leading public health expert and the former acting director of the Centers for Disease Control and Prevention. He has drawn on his experience to offer both criticism and commendation of global response efforts to the pandemic\, and has emphasized the health inequities being brought to light as a result. Join STAT’s senior infectious diseases and global health reporter\, Helen Branswell\, for a live video chat with Dr. Besser\, who is now president and CEO of the Robert Wood Johnson Foundation\, at 11 a.m. EDT on Monday\, April 27. They’ll be talking about the current state of the pandemic\, how communities across the country are being impacted\, and how we can work together in response. \nQuestions for Dr. Besser? Submit a question in advance when you register. \nHOW IT WORKS \nWe’ll be hosting this live chat as a Zoom webinar. Register here to sign up for the chat\, and we’ll reach out to you at the email address provided with a link to access the chat. A live stream link will also be provided. Please feel free to join there if the Zoom room is full. \nQUESTIONS? \nEmail us at subscribers@statnews.com
URL:https://scienceinboston.com/event/stat-video-chat-a-conversation-on-the-coronavirus-with-rich-besser/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/A-conversation-on-the-coronavirus-with-Rich-Besser.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200427T110000
DTEND;TZID=America/Vancouver:20200427T120000
DTSTAMP:20260417T070423
CREATED:20200422T173954Z
LAST-MODIFIED:20200422T173954Z
UID:27473-1587985200-1587988800@scienceinboston.com
SUMMARY:Stat Video Chat: A Conversation on the Coronavirus with Rich Besser
DESCRIPTION:Rich Besser is a leading public health expert and the former acting director of the Centers for Disease Control and Prevention. He has drawn on his experience to offer both criticism and commendation of global response efforts to the pandemic\, and has emphasized the health inequities being brought to light as a result. Join STAT’s senior infectious diseases and global health reporter\, Helen Branswell\, for a live video chat with Dr. Besser\, who is now president and CEO of the Robert Wood Johnson Foundation\, at 11 a.m. EDT on Monday\, April 27. They’ll be talking about the current state of the pandemic\, how communities across the country are being impacted\, and how we can work together in response. \nQuestions for Dr. Besser? Submit a question in advance when you register. \nHOW IT WORKS \nWe’ll be hosting this live chat as a Zoom webinar. Register here to sign up for the chat\, and we’ll reach out to you at the email address provided with a link to access the chat. A live stream link will also be provided. Please feel free to join there if the Zoom room is full. \nQUESTIONS? \nEmail us at subscribers@statnews.com
URL:https://scienceinboston.com/event/stat-video-chat-a-conversation-on-the-coronavirus-with-rich-besser-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/A-conversation-on-the-coronavirus-with-Rich-Besser.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200424T130000
DTEND;TZID=America/New_York:20200424T143000
DTSTAMP:20260417T070423
CREATED:20200417T172521Z
LAST-MODIFIED:20200417T172521Z
UID:8739-1587733200-1587738600@scienceinboston.com
SUMMARY:Boston University Postdoc Town Hall
DESCRIPTION:Join Professional Development & Postdoctoral Affairs for a town hall meeting to talk about the University’s current plans to address the impact of the COVID-19 crisis\, ask questions that relate to your postdoctoral experience (coronavirus-related or otherwise)\, and share your concerns with our team. Our panel will include:   Gloria Waters\, Vice President & Associate Provost for Research Sarah Hokanson\, Assistant Provost\, Professional Development & Postdoctoral Affairs Jennifer Grodsky\, Vice President\, Federal Relations Sharon Ralston\, Assistant Director for Scholar Services\, International Students & Scholars Office   The first 20 minutes of the event will feature overview presentations/remarks from each of our panelists\, and will be recorded for those postdocs unable to join us. The remaining time will not be recorded\, and will be devoted to Q&A. Based on the questions we receive\, we will develop a postdoc-specific FAQ for our website.\n\n \nSTARTS:\n1:00 pm on Friday\, April 24\, 2020\n \nENDS:\n2:30 pm on Friday\, April 24\, 2020\n \nLOCATION:\nZoom\n \nREGISTRATION:\nhttp://www.bu.edu/postdocs/pdpa-town-hall/
URL:https://scienceinboston.com/event/boston-university-postdoc-town-hall/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200424T130000
DTEND;TZID=America/New_York:20200424T143000
DTSTAMP:20260417T070423
CREATED:20200417T172521Z
LAST-MODIFIED:20200417T172521Z
UID:27459-1587733200-1587738600@scienceinboston.com
SUMMARY:Boston University Postdoc Town Hall
DESCRIPTION:Join Professional Development & Postdoctoral Affairs for a town hall meeting to talk about the University’s current plans to address the impact of the COVID-19 crisis\, ask questions that relate to your postdoctoral experience (coronavirus-related or otherwise)\, and share your concerns with our team. Our panel will include:   Gloria Waters\, Vice President & Associate Provost for Research Sarah Hokanson\, Assistant Provost\, Professional Development & Postdoctoral Affairs Jennifer Grodsky\, Vice President\, Federal Relations Sharon Ralston\, Assistant Director for Scholar Services\, International Students & Scholars Office   The first 20 minutes of the event will feature overview presentations/remarks from each of our panelists\, and will be recorded for those postdocs unable to join us. The remaining time will not be recorded\, and will be devoted to Q&A. Based on the questions we receive\, we will develop a postdoc-specific FAQ for our website.\n\n \nSTARTS:\n1:00 pm on Friday\, April 24\, 2020\n \nENDS:\n2:30 pm on Friday\, April 24\, 2020\n \nLOCATION:\nZoom\n \nREGISTRATION:\nhttp://www.bu.edu/postdocs/pdpa-town-hall/
URL:https://scienceinboston.com/event/boston-university-postdoc-town-hall-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200423T160000
DTEND;TZID=America/Vancouver:20200423T170000
DTSTAMP:20260417T070423
CREATED:20200420T220517Z
LAST-MODIFIED:20200420T220517Z
UID:8799-1587657600-1587661200@scienceinboston.com
SUMMARY:Community Forum on COVID-19 Research
DESCRIPTION:Want to learn about the latest COVID-19 research happening here at home?\nMeet online with researchers from the four federally-funded Clinical and Translational Science Awards institutions in Massachusetts (Tufts CTSI\, BU-CTSI\, Harvard Catalyst\, and UMass CCTS) to hear about how they’re working together to protect us from COVID-19. \nWe will offer a Community Forum each week for the next month so you can be part of these important conversations. \nPlease join us for our first Community Forum: Modeling the COVID Epidemic in Real Time\nby Joshua Cohen\, PhD of Tufts Medical Center and Tufts University School of Medicine. \nThursday\, April 23\, 4:00-5:00PM\, online via Zoom \nRegistration\nTo sign up\, please fill out this form: https://bit.ly/3cm15Mm. A link to the online meeting will be emailed to you. \nQuestions?\nPlease email mfenwood@tuftsmedicalcenter.org.
URL:https://scienceinboston.com/event/community-forum-on-covid-19-research/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200423T160000
DTEND;TZID=America/Vancouver:20200423T170000
DTSTAMP:20260417T070423
CREATED:20200420T220517Z
LAST-MODIFIED:20200420T220517Z
UID:27470-1587657600-1587661200@scienceinboston.com
SUMMARY:Community Forum on COVID-19 Research
DESCRIPTION:Want to learn about the latest COVID-19 research happening here at home?\nMeet online with researchers from the four federally-funded Clinical and Translational Science Awards institutions in Massachusetts (Tufts CTSI\, BU-CTSI\, Harvard Catalyst\, and UMass CCTS) to hear about how they’re working together to protect us from COVID-19. \nWe will offer a Community Forum each week for the next month so you can be part of these important conversations. \nPlease join us for our first Community Forum: Modeling the COVID Epidemic in Real Time\nby Joshua Cohen\, PhD of Tufts Medical Center and Tufts University School of Medicine. \nThursday\, April 23\, 4:00-5:00PM\, online via Zoom \nRegistration\nTo sign up\, please fill out this form: https://bit.ly/3cm15Mm. A link to the online meeting will be emailed to you. \nQuestions?\nPlease email mfenwood@tuftsmedicalcenter.org.
URL:https://scienceinboston.com/event/community-forum-on-covid-19-research-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T180000
DTEND;TZID=America/Vancouver:20200422T193000
DTSTAMP:20260417T070423
CREATED:20200417T210419Z
LAST-MODIFIED:20200417T210419Z
UID:8772-1587578400-1587583800@scienceinboston.com
SUMMARY:Fight COVID-19 with West – A Fundraiser Benefiting Life Science Cares COVID-19 Response Fund
DESCRIPTION:As COVID-19 continues to spread in Massachusetts and the Country\, we are reminded of how interconnected we are. These are challenging times for us all\, and WEST hopes to play a small role to help those in need! WEST is pleased to organize a special virtual panel discussion with the WEST Board and Advisory Board members. One hundred percent of the proceeds from this event will be donated to the Life Science Cares COVID-19 Response Fund providing flexible grants to organizations working to meet the emerging and shifting needs caused by this unprecedented outbreak. \nPanelists will share inspiration\, challenges\, advice\, and ways their companies are addressing issues with COVID-19. Join us to ask questions and share your experiences working remotely. \nThank you for being part of the WEST community. Without you\, this is not possible. \n\n\n  \nPanelists include: \n– Chesley Chen\, Chief Executive Officer at g.Root Biomedical\n– Eleanor Howe\, Founder and CEO of Diamond Age Data Science\n– Anne Thessen\, Assistant Professor (Senior Research)\, Oregon State University\n– Jo Viney\, Co-Founder\, President and CSO\, Pandion Therapeutics\n– Meena Subramanyam\, Vice President and Global Program Leader\, Gastroenterology\, Takeda\n(moderator) \nWe will also hear from Christine Casalini & Amber Black at Life Science Cares. \n  \nDate and Time: \nApril 22\, 2020\n6:00 – 7:30 PM \n6:00-6:05 PM: Welcome\, Update from Life Science Cares\n6:05-6:25 PM: Facilitated Networking\n6:25-7:15 PM: Panel Discussion\n7:15-7:30 PM: Q&A \n\nLocation: \nZoom \n\nCost:  \n$10 (all of which will be donated)
URL:https://scienceinboston.com/event/fight-covid-19-with-west-a-fundraiser-benefiting-life-science-cares-covid-19-response-fund/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T180000
DTEND;TZID=America/Vancouver:20200422T193000
DTSTAMP:20260417T070423
CREATED:20200417T210419Z
LAST-MODIFIED:20200417T210419Z
UID:27468-1587578400-1587583800@scienceinboston.com
SUMMARY:Fight COVID-19 with West – A Fundraiser Benefiting Life Science Cares COVID-19 Response Fund
DESCRIPTION:As COVID-19 continues to spread in Massachusetts and the Country\, we are reminded of how interconnected we are. These are challenging times for us all\, and WEST hopes to play a small role to help those in need! WEST is pleased to organize a special virtual panel discussion with the WEST Board and Advisory Board members. One hundred percent of the proceeds from this event will be donated to the Life Science Cares COVID-19 Response Fund providing flexible grants to organizations working to meet the emerging and shifting needs caused by this unprecedented outbreak. \nPanelists will share inspiration\, challenges\, advice\, and ways their companies are addressing issues with COVID-19. Join us to ask questions and share your experiences working remotely. \nThank you for being part of the WEST community. Without you\, this is not possible. \n\n\n  \nPanelists include: \n– Chesley Chen\, Chief Executive Officer at g.Root Biomedical\n– Eleanor Howe\, Founder and CEO of Diamond Age Data Science\n– Anne Thessen\, Assistant Professor (Senior Research)\, Oregon State University\n– Jo Viney\, Co-Founder\, President and CSO\, Pandion Therapeutics\n– Meena Subramanyam\, Vice President and Global Program Leader\, Gastroenterology\, Takeda\n(moderator) \nWe will also hear from Christine Casalini & Amber Black at Life Science Cares. \n  \nDate and Time: \nApril 22\, 2020\n6:00 – 7:30 PM \n6:00-6:05 PM: Welcome\, Update from Life Science Cares\n6:05-6:25 PM: Facilitated Networking\n6:25-7:15 PM: Panel Discussion\n7:15-7:30 PM: Q&A \n\nLocation: \nZoom \n\nCost:  \n$10 (all of which will be donated)
URL:https://scienceinboston.com/event/fight-covid-19-with-west-a-fundraiser-benefiting-life-science-cares-covid-19-response-fund-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T130000
DTEND;TZID=America/Vancouver:20200422T140000
DTSTAMP:20260417T070423
CREATED:20200415T182259Z
LAST-MODIFIED:20200415T182259Z
UID:8704-1587560400-1587564000@scienceinboston.com
SUMMARY:STAT Digital Event: Antiviral Treatments. What Are the Odds?
DESCRIPTION:The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nPart 2: Antiviral treatments. What are the odds? April 22\, 2020 at 1PM EST \n\nSponsor Introduction: Richard Moscicki\, M.D.\, chief medical officer and executive vice president of Science and Regulatory Advocacy\, PhRMA\nDiana Brainard\, senior vice president\, HIV and Emerging Viral Infections at Gilead Sciences\, Inc.\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinboston.com/event/stat-digital-event-antiviral-treatments-what-are-the-odds/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/STAT-Digital-Event-Series-Combating-Covid-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T130000
DTEND;TZID=America/Vancouver:20200422T140000
DTSTAMP:20260417T070423
CREATED:20200415T182259Z
LAST-MODIFIED:20200415T182259Z
UID:27452-1587560400-1587564000@scienceinboston.com
SUMMARY:STAT Digital Event: Antiviral Treatments. What Are the Odds?
DESCRIPTION:The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nPart 2: Antiviral treatments. What are the odds? April 22\, 2020 at 1PM EST \n\nSponsor Introduction: Richard Moscicki\, M.D.\, chief medical officer and executive vice president of Science and Regulatory Advocacy\, PhRMA\nDiana Brainard\, senior vice president\, HIV and Emerging Viral Infections at Gilead Sciences\, Inc.\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinboston.com/event/stat-digital-event-antiviral-treatments-what-are-the-odds-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/STAT-Digital-Event-Series-Combating-Covid-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T120000
DTEND;TZID=America/Vancouver:20200422T130000
DTSTAMP:20260417T070423
CREATED:20200415T223127Z
LAST-MODIFIED:20200415T223127Z
UID:8726-1587556800-1587560400@scienceinboston.com
SUMMARY:Strategic Approaches To Developing and Commercializing Companion Diagnostics
DESCRIPTION:The COVID-19 pandemic has proven the importance of diagnostic tests in overcoming healthcare crises and saving lives; but it has required rapid scale up and deployment of point of care and lab based tests hopefully with lessons learned for the future. Join us to learn more about the journey of developing a companion diagnostic from discovery through commercialization. \nPrecision medicine is an emerging method that factors in an individual’s molecular profile\, environment\, and lifestyle in order to prevent\, diagnose\, and treat diseases more effectively. It’s about considering individual differences in the course of prevention\, diagnosis\, and treatment. \nPatients can be classified into subgroups based on how susceptible they are to certain diseases\, how those diseases will develop\, or how they’ll respond to particular treatments. This information can then be used to predict what the most effective course of action will be. Companion Diagnostics are tools employed to identify those patients who are most likely to benefit from a particular therapeutic product\, highlight those at increased risk for serious side effects\, and monitor treatment response. \nBut what about those tasked with bringing precision medicine tests and treatments to the market? What are they doing\, what challenges do they face\, and how are they working with stakeholders within the wider healthcare ecosystem? We’ll follow the journey of developing a companion diagnostic from discovery through commercialization and answer those questions in this informative forum. Please come prepared with your questions. \nSponsored by the Medtech/Digital Health working group. \nNOTE: As MassBio transitions to virtual events\, we are striving to make them as inclusive as possible given the challenges and restrictions inherent in virtual events. Thank you for your understanding.
URL:https://scienceinboston.com/event/strategic-approaches-to-developing-and-commercializing-companion-diagnostics/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T120000
DTEND;TZID=America/Vancouver:20200422T130000
DTSTAMP:20260417T070423
CREATED:20200415T223127Z
LAST-MODIFIED:20200415T223127Z
UID:27454-1587556800-1587560400@scienceinboston.com
SUMMARY:Strategic Approaches To Developing and Commercializing Companion Diagnostics
DESCRIPTION:The COVID-19 pandemic has proven the importance of diagnostic tests in overcoming healthcare crises and saving lives; but it has required rapid scale up and deployment of point of care and lab based tests hopefully with lessons learned for the future. Join us to learn more about the journey of developing a companion diagnostic from discovery through commercialization. \nPrecision medicine is an emerging method that factors in an individual’s molecular profile\, environment\, and lifestyle in order to prevent\, diagnose\, and treat diseases more effectively. It’s about considering individual differences in the course of prevention\, diagnosis\, and treatment. \nPatients can be classified into subgroups based on how susceptible they are to certain diseases\, how those diseases will develop\, or how they’ll respond to particular treatments. This information can then be used to predict what the most effective course of action will be. Companion Diagnostics are tools employed to identify those patients who are most likely to benefit from a particular therapeutic product\, highlight those at increased risk for serious side effects\, and monitor treatment response. \nBut what about those tasked with bringing precision medicine tests and treatments to the market? What are they doing\, what challenges do they face\, and how are they working with stakeholders within the wider healthcare ecosystem? We’ll follow the journey of developing a companion diagnostic from discovery through commercialization and answer those questions in this informative forum. Please come prepared with your questions. \nSponsored by the Medtech/Digital Health working group. \nNOTE: As MassBio transitions to virtual events\, we are striving to make them as inclusive as possible given the challenges and restrictions inherent in virtual events. Thank you for your understanding.
URL:https://scienceinboston.com/event/strategic-approaches-to-developing-and-commercializing-companion-diagnostics-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200422T120000
DTEND;TZID=America/New_York:20200422T130000
DTSTAMP:20260417T070423
CREATED:20200406T145054Z
LAST-MODIFIED:20200406T145054Z
UID:8603-1587556800-1587560400@scienceinboston.com
SUMMARY:Every Cell Has Its Place: In Situ Sequencing of Tissue Samples at Single-Cell Resolution
DESCRIPTION:Single-cell RNA sequencing (scRNA-seq) has revolutionized the understanding of tissue complexity by dissecting transcriptomic heterogeneity and revealing previously unknown cell types and states. However\, scRNA-seq does not allow the visualization of spatial organization of single cells within the tissue. In order to overcome this limitation\, spatial gene expression profiling technologies have emerged that aim to localize molecularly defined cell types within the morphological context. In situ sequencing (ISS) can rapidly analyze and visualize the expression of hundreds of genes within morphologically intact tissue samples at single-cell resolution. ISS helps researchers to understand complex biological and pathological mechanisms and to localize and validate new drug targets. \nIn this webinar\, we will outline the benefits of ISS and showcase how it can complement spatial transcriptomics technology in the task of unraveling the role of amyloid-ß plaques in the neurogenerative process of Alzheimer’s disease. \nDuring this webinar\, the speakers will: \n\nIntroduce ISS technology and how it enables simultaneous spatial analysis of hundreds of genes in tissue samples at single-cell resolution\nShow how ISS has helped shed light on the role of amyloid-ß plaques in Alzheimer’s disease\nDiscuss applications and performance of ISS in other research areas\nAnswer your questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes. \n\nSpeaker bios\n\n\n\nBart De Strooper\, M.D.\, Ph.D.\nVIB-KU Leuven Center for Brain & Disease Research\nLeuven\, Belgium \n\nDr. DeStrooper graduated from KU Leuven\, first as a Doctor of Medicine (1985) and then as a Master’s in biomedical sciences (1987). After obtaining his doctorate in 1991 and completing postgraduate studies in 1999 under the supervision of Fred van Leuven and Carlos Dotti (European Molecular Biology Laboratory\, Germany)\, in which he studied presenilins in Alzheimer’s disease (AD)\, he started an independent research laboratory at KU Leuven and VIB. His multidisciplinary\, international research group has grown to 30 people\, and his lab studies both Alzheimer’s and Parkinson’s disease. His research spans biochemistry and enzymology of γ-secretase; microRNA biology and expression deregulation; genetic and transcriptomic analysis of AD patients’ brains; generation of novel humanized mouse models for AD; mitochondrial biology; and the development of nanobodies against therapeutically relevant targets. Currently\, Dr. DeStrooper is pioneering the application of single-cell genomics-transcriptomics and spatial transcriptomics to the study of Alzheimer’s disease. Since 2017 he has been founding director of the UK Dementia Research Institute. \n\n\n\n\n\n\nMalte Kuhnemund\, Ph.D.\nCARTANA\nSolna\, Sweden \n\nDr. Kühnemund obtained a Master’s in biochemistry and cell biology at the Braunschweig University of Technology (Germany) and Lund University (Sweden). He then joined the Nilsson and Landegren labs in Sweden\, where he obtained his Ph.D. in molecular medicine from Uppsala University and the Science for Life Laboratory (Sweden). His work on single-molecule analysis and sequencing technologies is now part of the technology portfolio of CARTANA\, an in-situ-sequencing (ISS) company spun out from the Nilsson lab. Dr. Kühnemund is a cofounder of CARTANA and head of R&D at the company\, which makes ISS technology available to the global research community. \n\n\n\n\n\n\nJackie Oberst\, Ph.D.\nScience/AAAS\nWashington\, D.C. \n\nDr. Oberst did her undergraduate training at the University of Maryland\, College Park\, and her Ph.D. in Tumor Biology at Georgetown University\, Washington D.C. She combined her interests in science and writing by pursuing an M.A. in Journalism from the Philip Merrill College of Journalism at the University of Maryland\, College Park. Dr. Oberst joined Science/AAAS in 2016 as the Assistant Editor for Custom Publishing. Before then she worked at Nature magazine\, the Howard Hughes Medical Institute\, The Endocrine Society\, and the National Institutes of Mental Health.
URL:https://scienceinboston.com/event/every-cell-has-its-place-in-situ-sequencing-of-tissue-samples-at-single-cell-resolution/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200422T120000
DTEND;TZID=America/New_York:20200422T130000
DTSTAMP:20260417T070423
CREATED:20200406T145054Z
LAST-MODIFIED:20200406T145054Z
UID:27446-1587556800-1587560400@scienceinboston.com
SUMMARY:Every Cell Has Its Place: In Situ Sequencing of Tissue Samples at Single-Cell Resolution
DESCRIPTION:Single-cell RNA sequencing (scRNA-seq) has revolutionized the understanding of tissue complexity by dissecting transcriptomic heterogeneity and revealing previously unknown cell types and states. However\, scRNA-seq does not allow the visualization of spatial organization of single cells within the tissue. In order to overcome this limitation\, spatial gene expression profiling technologies have emerged that aim to localize molecularly defined cell types within the morphological context. In situ sequencing (ISS) can rapidly analyze and visualize the expression of hundreds of genes within morphologically intact tissue samples at single-cell resolution. ISS helps researchers to understand complex biological and pathological mechanisms and to localize and validate new drug targets. \nIn this webinar\, we will outline the benefits of ISS and showcase how it can complement spatial transcriptomics technology in the task of unraveling the role of amyloid-ß plaques in the neurogenerative process of Alzheimer’s disease. \nDuring this webinar\, the speakers will: \n\nIntroduce ISS technology and how it enables simultaneous spatial analysis of hundreds of genes in tissue samples at single-cell resolution\nShow how ISS has helped shed light on the role of amyloid-ß plaques in Alzheimer’s disease\nDiscuss applications and performance of ISS in other research areas\nAnswer your questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes. \n\nSpeaker bios\n\n\n\nBart De Strooper\, M.D.\, Ph.D.\nVIB-KU Leuven Center for Brain & Disease Research\nLeuven\, Belgium \n\nDr. DeStrooper graduated from KU Leuven\, first as a Doctor of Medicine (1985) and then as a Master’s in biomedical sciences (1987). After obtaining his doctorate in 1991 and completing postgraduate studies in 1999 under the supervision of Fred van Leuven and Carlos Dotti (European Molecular Biology Laboratory\, Germany)\, in which he studied presenilins in Alzheimer’s disease (AD)\, he started an independent research laboratory at KU Leuven and VIB. His multidisciplinary\, international research group has grown to 30 people\, and his lab studies both Alzheimer’s and Parkinson’s disease. His research spans biochemistry and enzymology of γ-secretase; microRNA biology and expression deregulation; genetic and transcriptomic analysis of AD patients’ brains; generation of novel humanized mouse models for AD; mitochondrial biology; and the development of nanobodies against therapeutically relevant targets. Currently\, Dr. DeStrooper is pioneering the application of single-cell genomics-transcriptomics and spatial transcriptomics to the study of Alzheimer’s disease. Since 2017 he has been founding director of the UK Dementia Research Institute. \n\n\n\n\n\n\nMalte Kuhnemund\, Ph.D.\nCARTANA\nSolna\, Sweden \n\nDr. Kühnemund obtained a Master’s in biochemistry and cell biology at the Braunschweig University of Technology (Germany) and Lund University (Sweden). He then joined the Nilsson and Landegren labs in Sweden\, where he obtained his Ph.D. in molecular medicine from Uppsala University and the Science for Life Laboratory (Sweden). His work on single-molecule analysis and sequencing technologies is now part of the technology portfolio of CARTANA\, an in-situ-sequencing (ISS) company spun out from the Nilsson lab. Dr. Kühnemund is a cofounder of CARTANA and head of R&D at the company\, which makes ISS technology available to the global research community. \n\n\n\n\n\n\nJackie Oberst\, Ph.D.\nScience/AAAS\nWashington\, D.C. \n\nDr. Oberst did her undergraduate training at the University of Maryland\, College Park\, and her Ph.D. in Tumor Biology at Georgetown University\, Washington D.C. She combined her interests in science and writing by pursuing an M.A. in Journalism from the Philip Merrill College of Journalism at the University of Maryland\, College Park. Dr. Oberst joined Science/AAAS in 2016 as the Assistant Editor for Custom Publishing. Before then she worked at Nature magazine\, the Howard Hughes Medical Institute\, The Endocrine Society\, and the National Institutes of Mental Health.
URL:https://scienceinboston.com/event/every-cell-has-its-place-in-situ-sequencing-of-tissue-samples-at-single-cell-resolution-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR